Pneumococcal Disease
Showing 1 - 25 of 44
Pneumococcal Disease Trial in Chengdu (23-valent pneumococcal polysaccharide vaccine, control pneumococcal polysaccharide
Recruiting
- Pneumococcal Disease
- 23-valent pneumococcal polysaccharide vaccine
- control pneumococcal polysaccharide vaccine
-
Chengdu, Sichuan, ChinaSichuan Center For Disease Control and Prevention
Sep 19, 2023
Pneumococcal Disease Trial (XJ103 Injection, Placebo)
Not yet recruiting
- Pneumococcal Disease
- XJ103 Injection
- Placebo
- (no location specified)
Sep 6, 2023
Pneumococcal Disease Trial (20-valent pneumococcal conjugate vaccine)
Not yet recruiting
- Pneumococcal Disease
- 20-valent pneumococcal conjugate vaccine
- (no location specified)
May 16, 2023
Pneumococcal Disease Trial in Hialeah, Elkridge, San Antonio (Low dose multivalent pneumococcal conjugate vaccine formulation A,
Recruiting
- Pneumococcal Disease
- Low dose multivalent pneumococcal conjugate vaccine formulation A
- +3 more
-
Hialeah, Florida
- +2 more
Apr 27, 2023
Pneumococcal Disease Trial in Worldwide (V116, PPSV23)
Recruiting
- Pneumococcal Disease
- V116
- PPSV23
-
Blacktown, New South Wales, Australia
- +50 more
Jan 25, 2023
Pneumococcal Disease Trial in Japan (V116, PPSV23)
Recruiting
- Pneumococcal Disease
- V116
- PPSV23
-
Osaka-shi, Osaka, Japan
- +7 more
Jan 18, 2023
Pneumococcal Disease Trial (20-valent pneumococcal conjugate vaccine, 13-valent pneumococcal conjugate vaccine)
Recruiting
- Pneumococcal Disease
- 20-valent pneumococcal conjugate vaccine
- 13-valent pneumococcal conjugate vaccine
-
Budapest, Hungary
- +33 more
Jan 11, 2023
Pneumococcal Disease Trial in India (13-valent pneumococcal conjugate vaccine)
Completed
- Pneumococcal Disease
- 13-valent pneumococcal conjugate vaccine
-
Surat, Gujarat, India
- +4 more
Jan 10, 2023
Pneumococcal Disease Trial in Chile, United States (V116, Placebo, PCV15)
Active, not recruiting
- Pneumococcal Disease
- V116
- +3 more
-
Phoenix, Arizona
- +19 more
Dec 21, 2022
Pneumococcal Disease Trial in Japan, Korea, Republic of, Taiwan (20vPnC, Saline, 13vPnC)
Completed
- Pneumococcal Disease
- 20vPnC
- +3 more
-
Itoshima, Fukuoka, Japan
- +27 more
Dec 5, 2022
Pneumococcal Disease Trial in Worldwide (20-valent pneumococcal conjugate vaccine, 13-valent pneumococcal conjugate vaccine)
Active, not recruiting
- Pneumococcal Disease
- 20-valent pneumococcal conjugate vaccine
- 13-valent pneumococcal conjugate vaccine
-
Nedlands, Western Australia, Australia
- +63 more
Nov 3, 2022
Pneumococcal Disease Trial (20-valent pneumococcal conjugate vaccine, 13-valent pneumococcal conjugate vaccine)
Not yet recruiting
- Pneumococcal Disease
- 20-valent pneumococcal conjugate vaccine
- 13-valent pneumococcal conjugate vaccine
- (no location specified)
Aug 22, 2022
Pneumococcal Disease Trial in Worldwide (V116, PCV20)
Recruiting
- Pneumococcal Disease
- V116
- PCV20
-
Birmingham, Alabama
- +67 more
Aug 17, 2022
Pneumococcal Disease Trial in Korea, Republic of (V114)
Active, not recruiting
- Pneumococcal Disease
- V114
-
Jeonju-si, Jeonrabugdo, Korea, Republic of
- +18 more
Aug 17, 2022
Pneumococcal Disease Trial (Candidate-1, Candidate-2, Candidate-3)
Not yet recruiting
- Pneumococcal Disease
- Candidate-1
- +8 more
- (no location specified)
Aug 3, 2022
Pneumococcal Disease Trial in United States (V116, PPSV23)
Not yet recruiting
- Pneumococcal Disease
- V116
- PPSV23
- (no location specified)
Jul 12, 2022
Pneumococcal Disease Trial in United States (Experimental 20-valent pneumococcal conjugate vaccine (20vPnC), Saline, Influenza
Completed
- Pneumococcal Disease
- Experimental 20-valent pneumococcal conjugate vaccine (20vPnC)
- +2 more
-
Mobile, Alabama
- +62 more
Jun 15, 2022
Healthy Volunteers, Pneumococcal Disease Trial in United States (ASP3772, PCV13)
Completed
- Healthy Volunteers
- Pneumococcal Disease
- ASP3772
- PCV13
-
Bryant, Arkansas
- +16 more
Jun 2, 2022
Pneumococcal Disease Trial in United States (20vPnC)
Completed
- Pneumococcal Disease
- 20vPnC
-
Fayetteville, Arkansas
- +41 more
May 24, 2022
Healthy Volunteers, Pneumococcal Disease Trial in United States (ASP3772, PCV13, PPSV23)
Completed
- Healthy Volunteers
- Pneumococcal Disease
- ASP3772
- +2 more
-
Banning, California
- +25 more
Apr 27, 2022
Pneumococcal Disease, COVID-19, SARS-CoV-2 Infection Trial in United States (20-valent pneumococcal conjugate vaccine (20vPnC),
Completed
- Pneumococcal Disease
- +2 more
- 20-valent pneumococcal conjugate vaccine (20vPnC)
- +2 more
-
Anaheim, California
- +28 more
Mar 23, 2022
Pneumococcal Disease Trial in Seoul (EuPCV15, Prevenar13)
Completed
- Pneumococcal Disease
- EuPCV15
- Prevenar13
-
Seoul, Korea, Republic ofThe Catholic University of Seoul St.Mary's Hospital
Oct 6, 2021